Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

Pancreatology(2020)10.1016/j.pan.2020.01.005Source: DataRank Database

Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older is a research paper published in Pancreatology (2020). On theSindex it has a DataRank of 0. It has been cited 41 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access41 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.00)OA: greenTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Jane E. Rogers ORCID,Kenneth R. Hess ORCID,Robert A. Wolff ORCID,Gauri R. Varadhachary,Milind Javle ORCID

Live enrichment

PubMed:31932214 PMC:PMC7160008 OpenAlex:https://openalex.org/W31932214

NCI NIH HHS

Grant: T32 CA009666

NCI NIH HHS

Grant: P30 CA016672

NCATS NIH HHS

Grant: UL1 TR003167

National Institutes of Health T32 Ruth L. Kirschstein Institutional National Research Service Award

FWCI

0.00

Citation Percentile

0.0%

greenLicense: https://www.elsevier.com/legal/tdmrep-license

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/7160008

publisherhttps://api.elsevier.com/content/article/PII:S1424390320300053?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1424390320300053?httpAccept=text/plain

repositoryhttps://dialnet.unirioja.es/servlet/articulo?codigo=55670

Fields of Study

Ancient Egypt and ArchaeologyArchaeological and Historical Studies

MeSH Terms

HumansPancreatic NeoplasmsFluorouracilLeucovorinAntineoplastic AgentsAntimetabolites, AntineoplasticAntineoplastic Agents, PhytogenicAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalTreatment OutcomeSurvival AnalysisRetrospective StudiesAgedAged, 80 and overFemaleMaleKaplan-Meier EstimateIrinotecanOxaliplatin

Keywords

LinguisticsHistoryPhilosophySafetyChemotherapyElderlyRetrospective studiesGeriatric OncologyFolfirinox

Modified FOLFIRINOX in pancreatic cancer patients Age 75 or older

FAIR Checklist

Authors (12)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)